Pharmacy Podcast Network

• YARAL Pharma, Inc., which launched in 2022, is the U.S. generics subsidiary of IBSA, a long-standing, fully integrated, multinational pharmaceutical company headquartered in Lugano, Switzerland. Yaral is committed to providing high-quality products across a range of therapeutic areas, ensuring continuity of supply, and offering affordable authorized generics and complex generic medicines.    

Pete Johnson, Pharm.D. is Professor of Pharmacy Practice and President’s Associate Presidential Professor at the University of Oklahoma College of Pharmacy and Adjunct Professor at the University of Oklahoma College of Medicine in Oklahoma City, Oklahoma. Over the last 17 years, Dr. Johnson has practiced in both the Pediatric Intensive Care Unit (PICU) and Cardiac Intensive Care Unit (CICU) at Oklahoma Children's Hospital at OU Health. Currently, he spends most of his clinical time in the CICU where he also precepts pharmacy residents and students. Dr. Johnson serves as the Residency Program Director for the PGY2 Pediatric Pharmacy Residency at the OU College of Pharmacy. Dr. Johnson received his B.S. in Pharmaceutical Sciences and Doctor of Pharmacy degrees from the University of Mississippi School of Pharmacy. Following his tenure at Ole Miss, Dr. Johnson completed a Pharmacy Practice Residency followed by a Pediatric Pharmacy Practice Residency at the University of Kentucky Chandler Medical Center. He is board certified in Pediatric Pharmacy and is a fellow of the Pediatric Pharmacy Association (FPPA), American College of Critical Care Medicine (FCCM), and American Society of Health-System Pharmacy (ASHP). His research/scholarship focuses in pain management and sedation in children, pharmacokinetic alterations in critically ill children, and education/training in post-graduate pharmacy trainees.

• S. 2973, the Modernizing and Ensuring PBM Accountability (MEPA) Act (passed 26-1 out of the Senate Finance Committee)/H.R. 5378, the Lower Costs, More Transparency Act (passed the House of Representatives on an overwhelming bipartisan vote of 320-71)
  

• Bans spread pricing in Medicaid managed care by requiring a fair and transparent Medicaid reimbursement to pharmacies and saves over $1 billion!
  

• Includes the No PBMs Act which requires CMS to define reasonable and relevant contract terms in Medicare.
  

In this episode Robyn Amberg, a well-known industry figure interviews Bruce Kneeland and asks him to share examples of tactics he has seen pharmacy owners use to help them succeed.  Kneeland says one such tactic is for pharmacists to realize they are healthcare professionals with expertise in medications.  As healthcare professionals, they can provide a number of services that will generate new revenue and enhance their professional stature.  And he says he first witnessed some of these tactics 50 years ago when he was just starting his career.  It should be noted Robyn Amberg currently works for a major industry firm but prefers to not disclose the company.  She is also the daughter of Bruce Kneeland.  

Episode 2: Finding my niche in Pharmacy

On "This Week in Pharmacy" Diligent Robotics - Andrea L. Thomaz joins #TWIRx talking about how #Moxie Technology is positively impacting Hospital #Pharmacy.

With the scope of accountabilities and service offerings expanding in recent years, pharmacists are taking on more medical responsibilities beyond their traditional roles. Because of these increased accountabilities, medical billing is now more critical than ever. 

Pharmacy Times Continuing Education (PTCE) provides industry leading pharmacy CE to retail, oncology, managed care, specialty, and health-systems pharmacists. They use multiple deliverables in the live, virtual, on-demand, and print formats created by in-house pharmacists to deliver tailored multi-specialty education.

Title: Challenges in Treatment of Desmoid Tumors and Managed Care Solutions

Educational Objectives

Moderator:

Laura Bobolts, PharmD, BCOP

Senior Vice President of Clinical Strategy and Growth

OncoHealth

Plantation, Florida

Faculty:

Christy Harris, PharmD, BCOP, FHOPA    

Clinical Pharmacy Specialist                                                               

Dana-Farber Cancer Institute

Associate Professor

Massachusetts College of Pharmacy and Health Sciences

Boston, Massachusetts

Christy Harris, PharmD, BCOP, FHOPA and Laura Bobolts, PharmD, BCOP have no financial relationships with commercial interests to disclose.

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours (0.05 CEU) under the ACPE universal activity number 0290-0000-23-421-H01-P. The activity is available for CE credit through February 28, 2024.

This activity is supported by an educational grant from SpringWorks Therapeutics.